Strategic Collaboration Aims to Accelerate Global Access to Potentially Life-Saving VaccineCambridge, MA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Alopexx, Inc., a clinical-stage biotechnology company ...
Alopexx, Inc., a clinical-stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal, and ...
Bharat Biotech has taken legal action against 11 BHU researchers and the journal Drug Safety over a study on Covaxin's side ...
About Bharat Biotech International Limited (BBIL) Bharat Biotech (BBIL) is a biotech company in Genome Valley, Hyderabad, India. BBIL is a global leader with 145 patents, ~20 vaccines and bio ...
Bharat Biotech International Limited announced the release of HILLCHOL, an innovative single-strain oral cholera vaccine. Developed under license from Hilleman Laboratories, HILLCHOL aims to ...
Vaccine maker Bharat Biotech International Ltd on Tuesday (August 27, 2024) launched Hillchol (BBV131), a novel single-strain oral cholera vaccine (OCV) it has developed under licence from ...
Global demand for Oral Cholera Vaccines (OCVs) exceeds 100 million doses annually, making them crucial for cholera control. Globally, there is a shortage of OCVs as there is only one manufacturer.
HYDERABAD: Hyderabad-based vaccine manufacturer Bharat Biotech International Limited (BBIL) on Tuesday announced the launch of HILLCHOL (BBV131), a novel single-strain Oral Cholera Vaccine (OCV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback